Showing all 2 results

  • Placeholder

    CJC-1295 / Ipamorelin (No DAC)

    0 out of 5
    $59.99

    A combination of two GH secretagogues studied for synergistic stimulation of growth hormone release. CJC-1295 (No DAC / MOD GRF 1-29) binds GHRH receptors with a short half-life mimicking natural pulsatile GH secretion. Ipamorelin is a selective ghrelin receptor agonist with minimal cortisol or prolactin side effects in animal models. Together they are studied for…

  • Placeholder

    Tesamorelin

    0 out of 5
    $69.99

    A synthetic analog of growth hormone-releasing hormone (GHRH) studied for its selective stimulation of GH secretion from the pituitary gland. Research has examined its effects on visceral fat reduction, metabolic markers, and GH/IGF-1 axis modulation. Clinically approved for HIV-associated lipodystrophy; studied more broadly for its metabolic and body composition effects. For research use only.

End of content

End of content